Pengxu focuses on the development of APIs with high technical barrier and supplies the related intermediates. Based on our internal “RTPD”（Risk-Taking Product Development）and “CCPS” (Chemistry, Cost, Patent, and Safety) systems, we select right target molecules, develop cost-effective non-infringing process well ahead of other competitors, and work with our partners on novel polymorph forms. Through API technology licensing and key intermediates supplying, we support our customers’ API production and help them to secure a leading status in First-to-File type of generic.

Pengxu was established in 2011 and our R&D center is located in Suzhou, China. We currently have a R&D team of 30 scientists, including 4 PhDs and a dedicated analytical team. We have 1700 m2 lab space, necessary equipments including 4 HPLC&GC systems, kilo labs, and two sites that can handle industrial scale intermediate production.